Comparing Survival Outcomes in Peritoneal Dialysis and Hemodialysis

  • K.E. Yeates
  • P.G. Blake

Since the emergence of peritoneal dialysis (PD) as a widely used, feasible, and successful home-based therapy in the 1980s, there has inevitably been interest in comparing outcomes on this modality with those on hemodialysis (HD). Many studies have been done comparing costs of treatment, quality of life, and hospitalization and results have been variable [1–12]. Most important and most controversial, however, have been the studies that have attempted to compare patient survival on PD to that on HD [13–27].


Peritoneal Dialysis Peritoneal Dialysis Patient Residual Renal Function Dialysis Modality Registry Base Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Habach G, Bloembergen WE, Mauger EA, Wolfe RA, Port FK. Hospitalization among United States dialysis patients: hemodialysis versus peritoneal dialysis. J Am Soc Nephrol 1995; 5:1940–1948.PubMedGoogle Scholar
  2. 2.
    Murphy SW, Foley RN, Barrett BJ, et al. Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Kidney Int 2000; 57: 2557–2563.CrossRefPubMedGoogle Scholar
  3. 3.
    Kutner NG, Zhang R, Barnhart H, Collins AJ. Health Status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant 2005; 20: 2159–2167.CrossRefPubMedGoogle Scholar
  4. 4.
    Wu AW, Fink NE, Marsh-Manzi VR, Meyer KB, Finkelstein FO, Chapman MM, Powe NR. Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. J Am Soc Nephrol 15; 15: 743–753.Google Scholar
  5. 5.
    Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The NECOSAD Study Group. Am J Kidney Dis 1997; 29: 584–592.CrossRefPubMedGoogle Scholar
  6. 6.
    Simmons RG, Anderson C, Kamstra L. Comparison of quality of life of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and after transplantation. Am J Kidney Dis 1984; 4: 253–255.PubMedGoogle Scholar
  7. 7.
    Manns B, Johnson JA, Taub K, Mortis G, Ghaly WA, Donaldson C. Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants? Clin Nephrol 2003; 60: 341–351.PubMedGoogle Scholar
  8. 8.
    De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies – an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14 Suppl 6: 31–41.CrossRefPubMedGoogle Scholar
  9. 9.
    USRDS US Renal Data System, USRDS 2007 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Chapter 11. Costs of Chronic Kidney Disease and End Stage Renal Disease. National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases: Bethesda, MD, 2007.Google Scholar
  10. 10.
    Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40 (3): 611–622.CrossRefPubMedGoogle Scholar
  11. 11.
    Goeree R, Manalich J, Grootendorst P, Beecroft ML, Churchill DN. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med 1995; 18 (6): 455–464.PubMedGoogle Scholar
  12. 12.
    Salonen T, Reina T, Oksa H, Sintonen H, Pasternack A. Cost analysis of renal replacement therapies in Finland. Am J Kidney Dis 2003; 42: 1228–1238.CrossRefPubMedGoogle Scholar
  13. 13.
    Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 177–183.PubMedGoogle Scholar
  14. 14.
    Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10: 354–365.PubMedGoogle Scholar
  15. 15.
    Fenton SS, Schaubel DE, Desmeules M, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334–342.CrossRefPubMedGoogle Scholar
  16. 16.
    Schaubel DE, Morrisson HI, Fenton SS. Comparing mortality rates on CAPD/CCPD and hemodialysis. The Canadian experience: fact or fiction? Perit Dial Int 1998; 18: 478–484.PubMedGoogle Scholar
  17. 17.
    Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065–1074.CrossRefPubMedGoogle Scholar
  18. 18.
    Ganesh SK, Hulbert-Shearon T, Port FK, et al. Mortality differences by dialysis modality among Incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol. 2003; 14: 415–424.CrossRefPubMedGoogle Scholar
  19. 19.
    Stack AG, Molony DA, Rahman NS, et al. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003; 64: 1071–1079.CrossRefPubMedGoogle Scholar
  20. 20.
    Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004; 66: 2389–2401.CrossRefPubMedGoogle Scholar
  21. 21.
    Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002; 17: 112–117.CrossRefPubMedGoogle Scholar
  22. 22.
    Liem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int 2007; 71 (2): 153–158. Epub 29 Nov 2006.Google Scholar
  23. 23.
    Locatelli F, Marcelli D, Conte F, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001; 12: 2411–2417.PubMedGoogle Scholar
  24. 24.
    Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, Krediet RT; NECOSAD Study Group. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003; 64: 2222–2228.CrossRefPubMedGoogle Scholar
  25. 25.
    Murphy SW, Foley RN, Barrett BJ, et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int 2000; 57: 1720–1726.CrossRefPubMedGoogle Scholar
  26. 26.
    Jaar BG, Coresh J, Plantinga LC, et al. Comparing the risk of death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med2005; 143:174–183.PubMedGoogle Scholar
  27. 27.
    Termorshuizen F, Korevaar JC, Dekker FW, et al. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 2003; 14: 2851–2860.CrossRefPubMedGoogle Scholar
  28. 28.
    Blake PG, Finkelstein FO. Why is the proportion of patients doing peritoneal dialysis declining in North America? Perit Dial Int 2001; 21: 107–114.PubMedGoogle Scholar
  29. 29.
    Van Biesen W, Vanholder R, Debacquer D, De Backer G, Lameire N. Comparison of survival on CAPD and haemodialysis: statistical pitfalls. Nephrol Dial Transplant 2000; 15: 307–311.CrossRefPubMedGoogle Scholar
  30. 30.
    Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pleskey JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol 2002; 13: 2353–2362.CrossRefPubMedGoogle Scholar
  31. 31.
    Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int 2006; 70: S3–S11.CrossRefGoogle Scholar
  32. 32.
    Bargman JM. Is there more to living than not dying? A reflection on survival studies in dialysis. Semin Dial 2007; 20: 50–52.CrossRefPubMedGoogle Scholar
  33. 33.
    Longnecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe N. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. J Am Soc Nephrol 2000; 11: 520–529.Google Scholar
  34. 34.
    Bargman JM. Worshipping at the altar of St. Cox: who adjusts the adjustments? Perit Dial Int 2006; 26: 426–428.PubMedGoogle Scholar
  35. 35.
    D’Agostino RB Jr. Tutorial in biostatistics. Propensity score methods for a bias reduction in the comparison of a treatment to a non-randomized control group.Stat Med 1998; 17: 2265–2281.CrossRefPubMedGoogle Scholar
  36. 36.
    Ho YW, Chau KF, Leung CB, Choy BY, Tsang WK, Wong PN, Cheng YL, Lai Wm, Yong DSP, Kwan TH, Lui SF. Hong Kong Registry Report. Hong Kong J Nephrol 2004;7: 38–46.CrossRefGoogle Scholar
  37. 37.
    US Renal Data System, USRDS 2007 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Chapter 4. Treatment Modalities. National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases: Bethesda, MD, 2007.Google Scholar
  38. 38.
    Schaubel DE, Blake PG, Fenton SS. Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis. Kidney Int 2001; 60: 1517–1524.CrossRefPubMedGoogle Scholar
  39. 39.
    Churchill DN, Thorpe KE, Keshaviah PK. Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1997; 8: 965–971.PubMedGoogle Scholar
  40. 40.
    Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000; 11 (1): 116–125.PubMedGoogle Scholar
  41. 41.
    Blake PG. Integrated end-stage renal disease care: the role of peritoneal dialysis. Nephrol Dial Transplant 2001; 16 Suppl 5: 61–66.PubMedGoogle Scholar
  42. 42.
    Piraino B. The Choice Study. Perit Dial Int 2006; 26: 423–425.PubMedGoogle Scholar
  43. 43.
    Lo WK. Randomized control trial versus retrospective data. Semin Dial 2007; 20: 213–216.CrossRefPubMedGoogle Scholar
  44. 44.
    Garcia-Garcia G, Monteon-Ramos JF, Garcia-Bejarano H, Gomez-Navarro B, Reyes IH, Lomeli AM, Palomeque M, Cortes-Sanabria L, Breien-Alcaraz H, Ruiz-Morales NM. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL). Kidney Int Suppl 2005; 97: S58–S61.CrossRefPubMedGoogle Scholar
  45. 45.
    Van Laecke S, Veys N, Vekbeke F, Vanholder R, Van Biesen W. The fate of older diabetic patients on peritoneal dialysis: myths and mysteries and suggestions for further research. Perit Dial Int 2007; 27 (6): 611–618.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Professor of Medicine, Division of Nephrology, Department of MedicineLondon Health Sciences Centre and University of Western OntarioLondon

Personalised recommendations